Want to join the conversation?
Medical device major $COO reported a higher 2Q16 profit, helped by strong performance at its largest CooperVision segment. For the quarter, the company reported net earnings of $74.13MM, or $1.52 per share, compared with earnings of $60.71MM, or $1.23 per share a year ago. Revenue rose 11% o $483.8MM.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?